Better together: biomimetic nanomedicines for high performance tumor therapy

• Imran Shair Mohammad,
• Gizem Kursunluoglu,
• Anup Kumar Patel,
• Hafiz Muhammad Ishaq,
• Cansu Umran Tunc,
• Dilek Kanarya,
• Mubashar Rehman,
• Omer Aydin and
• Yin Lifang

Beilstein J. Nanotechnol. 2025, 16, 1246–1276, doi:10.3762/bjnano.16.92

• inherent traits endow biomimetic nanoparticles with a suite of intelligent features, including biocompatibility, low immunogenicity, reduced toxicity, immune evasion, prolonged circulation, homotypic binding, enhanced tumor targeting, and the capability of precise delivery. By integrating biologically

• utility, biomimetic nanoparticles hold great promise for advancing the field of cancer treatment. Keywords: biomimetic nanoparticles; homotypic binding; nanomaterials; targeted drug delivery; tumor therapy; Introduction Cancer is a complex disease, which involves numerous cells and their crosstalk with

• penetration of drugs and drug carriers. In addition, cancer cell membranes express specific receptors and antigens that help them recognize and target through a homotypic binding mechanism [44][45]. Therefore, cancer cell membranes are also extensively explored to localize nanomedicines to cancer cells

Bioselectivity of silk protein-based materials and their bio-inspired applications

• Hendrik Bargel,
• Vanessa T. Trossmann,
• Christoph Sommer and
• Thomas Scheibel

Beilstein J. Nanotechnol. 2022, 13, 902–921, doi:10.3762/bjnano.13.81

• one cell is responsible for mediating homotypic binding contacts with their homologues on an adjacent cell in an antiparallel manner. This region also defines binding specificity [15]. Some cadherin receptors are also able to bind to different cadherins. Classic cadherin function is involved in key